374 related articles for article (PubMed ID: 30655210)
1. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection.
Garcia-Carretero R; Vigil-Medina L; Barquero-Perez O; Ramos-Lopez J
Metab Syndr Relat Disord; 2019 Nov; 17(9):444-451. PubMed ID: 31675274
[No Abstract] [Full Text] [Related]
4. Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
Onitsuka Y; Takeshima F; Ichikawa T; Kohno S; Nakao K
Intern Med; 2014; 53(6):545-53. PubMed ID: 24633023
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study.
Shaikh A; Pedra G; Ruiz-Casas L; Franks B; Dhillon H; Fernandes JDDR; Mangla KK; Augusto M; Romero-Gómez M; Schattenberg JM
Gastroenterol Hepatol; 2024 May; 47(5):463-472. PubMed ID: 37890583
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
11. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
13. A population-based study on the prevalence of NASH using scores validated against liver histology.
Hyysalo J; Männistö VT; Zhou Y; Arola J; Kärjä V; Leivonen M; Juuti A; Jaser N; Lallukka S; Käkelä P; Venesmaa S; Simonen M; Saltevo J; Moilanen L; Korpi-Hyövalti E; Keinänen-Kiukaanniemi S; Oksa H; Orho-Melander M; Valenti L; Fargion S; Pihlajamäki J; Peltonen M; Yki-Järvinen H
J Hepatol; 2014 Apr; 60(4):839-46. PubMed ID: 24333862
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
16. Metabolic disorders across the body mass index spectrum in a Colombian population with nonalcoholic fatty liver disease.
Builes-Montaño CE; Pérez-Giraldo E; Castro-Sánchez S; Rojas-Henao NA; Santos-Sánchez OM; Restrepo-Gutiérrez JC
Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):64-69. PubMed ID: 37088640
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care].
Samperio-González MA; Selvi-Blasco M; Manzano-Montero M; Méndez-Gómez J; Gil-Prades M; Azagra R
Aten Primaria; 2016 May; 48(5):281-7. PubMed ID: 26441288
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan.
Shah AS; Khan S; Rahim H; Chishti KA; Khan AG
Pak J Pharm Sci; 2018 Jan; 31(1):193-198. PubMed ID: 29348103
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]